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Resveratrol (R-3), a trihydroxy trans-stilbene from grape, inhibits multistage carcinogenesis in animal models. A resveratrol derivative
3,4,5,40-tetrahydroxystilbene (R-4) exhibits potent growth inhibitory effect against transformed human cells. Here we report that
3,4,5,40-tetramethoxystilbene (MR-4), converted from R-4, was more potent against cancer cell lines (WI38VA, IMR-90SV, HeLa,
LNCaP, HT-29, and HepG2), but had almost no inhibitory effect on the growth of normal cells (WI38, IMR-90, BJ-T) at the
concentrations tested. The IC50 value of MR-4 on the growth inhibition of transformed WI38VA human cells was 0.5mM,a s
compared to the value of greater than 50mM for the normal WI38 cells. Resveratrol, however, did not exhibit such clear differential
effect and the IC50 value of R-3 for WI38VA cells was about 50mM. The growth inhibitory effect of MR-4 correlated with the
induction of apoptosis in the transformed cells. When normal WI38 cells and transformed WI38VA cells were compared, MR-4
induced increases of the Bax/Bcl-2 mRNA ratio, p53 and Bax protein level, activation of caspases, and DNA fragmentation in
transformed, but not in normal cells. Further analysis revealed that MR-4 caused a rapid appearance of perinuclear aggregation of
mitochondria in WI38VA but not in WI38 cells, suggesting that the mitochondria could serve as an early target of MR-4. R-3 also
induced apoptosis and mitochondrial clustering but only at a much higher concentration, close to 500mM. Taken together, the specific
activation of the mitochondria-mediated apoptotic pathway could be a major reason for the striking differential growth inhibitory
effect of MR-4.
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Resveratrol (3,5,40-trihydroxy-trans-stilbene), a phytoalexin pre-
sent in grapes, peanuts, and pines, has antioxidant and anti-
inflammatory activities (Jeandet et al, 1991), and is the active
ingredient in Leguminosae that inhibits cellular events associated
with tumour initiation, promotion, and progression in mouse skin
cancer model (Jang et al, 1997). In vitro, resveratrol inhibits the
growth of various human tumour cells, including oral squamous
carcinoma (Elattar and Virji, 1999), promyelocytic leukemia (Surh
et al, 1999), human breast cancer cells (Lu and Serrero, 1999),
prostate cancer cells (Hsieh and Wu, 1999; Narayanan et al, 2003),
oesophageal carcinoma cells (Zhou et al, 2003), pancreatic cancer
cells (Ding and Adrian, 2002), and monocytic leukaemia cell (Tsan
et al, 2000). The potential of resveratrol as a cancer chemopreven-
tion reagent has been extensively reviewed (Gusman et al, 2001;
Bhat and Pezzuto, 2002; Savouret and Quesne, 2002; Aziz et al,
2003). The possible role of resveratrol, a phytoestrogen, in
cardiovascular protection has also been discussed recently (Hung
et al, 2001; Wu et al, 2001). Nevertheless, there are two concerns
with regard to the use of resveratrol as chemoprevention agent.
First, most of the reported studies did not use paired normal and
cancer cells to compare the effects of resveratrol. For effective
chemoprevention, it is desirable that the candidate compound
demonstrates clear differential growth inhibitory effect against
cancer cells. Second, the IC50 of growth inhibition for resveratrol,
which varied between 40 and 200mM as reported in the literature
for various cell types, is relatively high. To address these concerns,
we have used a matched pair of normal and transformed human
fibroblasts to compare the antiproliferative activity of resveratrol
and other analogues derived from resveratrol (Lu et al, 2001). We
have observed a selective induction of apoptosis in cancer cells by
R-4 (3,4,5,40-tetrahydroxystilbene) (Lu et al, 2001).
Apoptosis can be considered as a proactive self-defense
mechanism of a living organism to weed out dysfunctional cells
such as the precursors of metastatic cancer cells without creating
secondary oxidative stress due to inflammation (Davies, 2000).
Aberration of apoptotic pathways leads to cancer and other
diseases (Igney and Krammer, 2002; Reed, 2003). Apoptosis is
defined by a set of energy-dependent changes including chromatin
condensation, DNA fragmentation, membrane blebbing, and cell
shrinkage. These events lead ultimately to cell death (Green and
Reed, 1998; Hengartner, 2000; Reed, 2002; vanGurp et al, 2003).
There exist two major pathways that initiate apoptosis: the
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sextrinsic (receptor-mediated) and intrinsic (mitochondria-
mediated) pathway, which can crosstalk to each other (Green
and Reed, 1998; Hengartner, 2000; Reed, 2002; vanGurp et al, 2003;
Gosslau and Chen, 2004). The extrinsic pathway is triggered by the
binding of ligands (e.g. TNF) to their cell death receptors (TNF-
receptor) located on the plasma membrane (Strater and Moller,
2000; Peter and Krammer, 2003). Activation is triggered by
receptor trimerisation and recruitment of associated proteins,
which result in activation of procaspase-8 and caspase-3 activation
(Strater and Moller, 2000; Peter and Krammer, 2003; Gosslau and
Chen, 2004).
The crucial step in the mitochondria-mediated apoptosis is the
change of mitochondrial membrane permeability, and collapse of
membrane potential (Green and Reed, 1998; Hengartner, 2000;
Reed, 2002; vanGurp et al, 2003; Gosslau and Chen, 2004). The
change can be induced by (i) an opening of the permeability
transition pore (PTP); (ii) an increase of the Bax/Bcl-2 ratio; or (iii)
reactive oxygen species (ROS)-induced damage of mitochondrial
membrane (Green and Reed, 1998; Hengartner, 2000; Reed, 2002;
vanGurp et al, 2003; Gosslau and Chen, 2004). The change in
membrane permeability causes mitochondrial swelling, rupture of
the outer membrane, and release of proapoptotic factors such as
cytochrome c, pro-caspases, Apaf-1, and AIF, from the intermem-
branous space, which leads to the formation of a supramolecular
apoptosome complex that turns on the caspase cascade (Green and
Reed, 1998; vanGurp et al, 2003). Increase of the Bax/Bcl-2 ratio is
proapoptotic by inducing permeabilisation of mitochondria.
Caspase-3 serves as the ‘central executioner of apoptosis’ since it
is activated by the extrinsic as well as intrinsic pathway (Susin et al,
1997). Caspase-3 activates other caspases, cleaves cytoskeletal
proteins (e.g. fodrin and gelsolin), or activates the caspase-
activated DNase (CAD), which is involved in fragmentation of
nuclear DNA. The characteristic cleavage of DNA into nucleosomal
fragments has been regarded as a hallmark of apoptosis (Compton,
1992).
Recently, we reported that among eight resveratrol derivatives,
R-4 (3,4,5,40-tetrahydroxy-trans-stilbene) inhibited the growth of
transformed cells, but had little effect on the growth of the normal
cells (Lu et al, 2001). We now report that MR-4 (3,4,5,40-
tetramethoxy-trans-stilbene), the methoxy derivative of R-4,
exhibits a striking differential growth inhibitory effect in several
different cancer cell lines. Noteworthy, MR-4 selectively eliminated
cancer cells by inducing apoptosis and the apoptotic signalling
may be triggered at mitochondria, which show very early
perinuclear aggregation after MR-4 treatment. Taken together,
our study suggests that resveratrol may serve as a useful chemical
platform for generating more potent anticancer compounds
targeting at mitochondria-mediated apoptotic pathway.
MATERIALS AND METHODS
Materials and chemicals
Dulbecco’s modified Eagle’s medium (DMEM) and fetal bovine
serum (FBS) were obtained from Gibco BRL (Gaithersburg, MD,
USA). [a-
33P]dCTP was purchased from Perkin Elmer (Boston,
MA, USA). Oligo-dT, poly-dA, dNTPs, Superscriptt II reverse
transcriptase, Cot-1 DNA, MicroHyb hybridisation solution were
purchased from Invitrogen Life Technologies (Baltimore, MD,
USA). Anti-p53 antibody conjugated to horseradish peroxidase
(polyclonal BMG-1B1) was purchased from Roche (Indianapolis,
IN, USA), and antibodies for Bax, Bcl-2, and b-actin were from
Santa Cruz iotechnology (Santa Cruz, CA, USA). Secondary anti-
mouse (NIF 825) and anti-rabbit (NIF 824) conjugated to horse-
radish peroxidase were from Amersham Pharmacia (Piscataway,
NJ, USA). Other chemicals were purchased from Sigma (St Louis,
MO, USA).
Preparation of resveratrol (R-3) and and 3,4,40,50-
tetramethoxystilbene (MR-4).
Polyhydroxystilbenes and polymethoxystilbenes are designated as
R or MR followed by a number indicating the number of hydroxyl
or methoxyl groups (Lu et al, 2001). Whereas the natural occurring
R-3 (3,5,40-trihydroxy-trans-stilbene) contains only two hydroxyl
groups in the first benzene ring, its analogues R-4 (3,4,5,40-
tetrahydroxy-trans-stilbene) and MR-4 (3,4,5,40-tetramethoxy-
trans-stilbene) contain, respectively, three hydroxyl and methoxyl
groups. The second benzene ring is either hydroxylated (R-3 and
R-4) or methoxylated (MR-4). The synthesis of resveratrol using 4-
methoxybenzyl alcohol and 3,5-dimethoxy-benzaldehyde as the
starting materials has been described (Bachelor et al, 1970; Drewes
and Fletcher, 1974). Similar strategy was employed to prepare MR-
4. The identity and purity of each of these compounds has been
confirmed by thin layer chromatography, NMR and GC-mass
spectroscopy.
Cell culture and treatment
Different human normal cells including WI38 (normal lung
fibroblasts), BJ-T (normal foreskin fibroblasts transfected with
telomerase), and IMR-90 (normal fibroblasts) or human tumour
cell lines including WI38VA (transformed lung fibroblasts), IMR-
90SV (transformed fibroblast), HeLa (cervix cancer), LNCaP
(prostate cancer), HT-29 (colon cancer), and HepG2 (hepatoma
cells) were obtained from the National Institute on Aging
Repository (Coriell Institute for Medical Research, Camden, NJ,
USA). Cells were cultured in Dulbecco’s modified Eagles medium
(DMEM) supplemented with 10% FBS at 371C in a humidified, 10%
CO2 atmosphere. Cells were subcultured in culture flasks (Falcon,
Becton-Dickinson, Franklin Lakes, NJ, USA) and passaged every 3
days. Before experiments, cells were seeded either in 88, 35-mm
culture dishes or in 24-well plates (Falcon, Becton-Dickinson,
Franklin Lakes, NJ, USA) as indicated for the different assays to
establish a confluent monolayer for untreated control cells at the
end of the experiment. Different stock solutions of R-3 or MR-4 in
DMSO were applied to the medium.
Cellular proliferation assays and morphological analysis
Cell proliferation was measured by the MTT (3(4,5-dimethylthia-
zol-2-yl)-2,5-diphenyl-tetrazolium-bromide) method, crystal violet
staining, or by cell counting. For the MTT- and crystal violet assay,
cells were treated in 24-well plates for 5 days, whereas for the
counting cell numbers were determined at designated time points.
The MTT-assay, based on the conversion of the tetrazolium salt
MTT to blue formazan by mitochondrial dehydrogenase, measures
mitochondrial damage (Berg et al, 1990). Owingto the concern that
MTT assay may yield false-positive results for certain cell types
when treated with flavonoids or polyphenols (Bernhard et al,
2003), we also included the crystal violet dye staining assay in this
study (Lu et al, 2001). Colour development was documented by a
scanner (UMAX, Astra 2200). For the counting method cells were
analysed by phase contrast light microscopy and documented
using a digital camera system (MDS 120, Kodak, Emeryville, CA,
USA). For morphological analysis, cells were treated in 35-mm cell
culture dishes for 5 days. Morphological analysis was performed
by phase contrast light microscopy and documented by the digital
camera system (MDS 120, Kodak, Emeryville, CA, USA).
DNA fragmentation assay
After treatment in 60-mm culture dishes, cells were harvested
and resuspended in 500ml of lysis buffer (0.5% (wv
 1) sodium
lauryl sarkosinateþ10mM EDTAþ0.5mgml
 1 proteinase
Kþ0.1mgml
 1 RNase A in 50mM Tris-Base, pH 8.0). After an
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sincubation for 40min at 371C, proteins were precipitated in 1 M
NaCl at 41C for 1h, followed by a centrifugation (10000 g for
10min). DNA from the supernatant was then extracted with a
phenol/chloroform/isopropanol mixture (25:24:1, pH 8.0), pre-
cipitated by ethanol (70%), and dried in a Speed Vac. For
separation, DNA pellets were resuspended in water (20ml) and
10ml of DNA laddering loading buffer (1% low-gelling temperature
agarose (wv
 1)þ0.25% bromphenol blue (wv
 1)þ40% sucrose
in 10ml EDTA, pH 8.0), which was heated to 1001C, previously.
After loading onto a 2% agarose gel, the samples were solidified
for 1h. Thereafter, DNA samples were separated by electrophor-
esis, stained by ethidium bromide and visualised under UV
illumination.
Caspase activation assay
The effect of MR-4 on caspase activation was analysed by
CaspACEtFITC-VAD-FMK in situ marker (Promega, Madison,
WI, USA), which is a fluoroisothiocyanate (FITC) conjugate of the
cell permeable caspase inhibitor VAD-FMK. The structure allows
delivery of the inhibitor into the cells where it binds to activated
caspases. Cells were seeded on coverslips 2 days before experi-
ment. After treatment, cells on coverslips were transferred onto a
35-mm dish containing 1ml of medium. Then, 2ml of CaspACE-
solution were applied to the medium to achieve a final
concentration of 10mM. After an incubation for 20min, cells were
analysed by fluorescent microscopy using an excitation wavelength
of 480nm.
Reverse transcription–polymerase chain reaction
(RT–PCR)
After treatment, cells were harvested at indicated times and the
total RNA was prepared using RNeasyt Total RNA Kit (Qiagen,
Chatsworth, CA, USA). Then, total RNA (1mg) was reverse
transcribed into cDNA by incubating with SuperScriptTM RNase
H reverse transcriptase (Invitrogen Life Technologies, Baltimore,
MD, USA) using oligo(dT)12 18 as primer (Invitrogen Life
Technologies, Baltimore, MD, USA). For PCR amplification, gene
specific primers, both sense and antisense, were used. The
sequences of these primers were:
(Bax sense)¼50-CTg ACA TgT TTT CTg ACg gC-30;
(Bax antisense)¼50-TCA gCC CAT CTT CTT CCA gA-30;
(Bcl-2 sense)¼50-ACT TgT ggC CCA gAT Agg CAC CCA g -30;
(Bcl-2 antisense)¼50-gCg ACT TCg CCg AgA TgT CCA gC-30;
(GAPDH sense)¼50-TgA AgC TCg gAg TCA Acg gAT TTg-30;
(GAPDH antisense)¼50-CAT gTg ggC CAT gAg gTC CAC CAC-30.
PCR conditions were chosen to ensure that the yield of the
amplified product was linear with respect to the amount of input
RNA. The expression of glyceraldehyde-3-phosphate dehydrogen-
ase (GAPDH), a housekeeping gene, was used as an internal
control. The PCR products were analysed by electrophoresis on a
1% agarose gel and visualised by ethidium bromide staining.
SDS–PAGE and Western blot
After treatment, cells were harvested, washed, heated, and
sonicated in lysis buffer (5mM Tris-base (pH 6.8), 5% 2-
mercaptoethanol, 3% sodiumdodecylsulfate (SDS), 10% glycerol).
After centrifugation (18000 g for 10min at 201C), equal amounts
of protein were separated by SDS–PAGE (10%) and transferred
onto a nitrocellulose membrane for Western blot analysis. Blots
were blocked with 1% skim milk and 0.2% Tween 20 in phosphate-
buffered saline (PBST) for 0.5h at room temperature. Primary
antibodies used were: anti-p53 antibody conjugated to horseradish
peroxidase (polyclonal BMG-1B1, Roche, Indianapolis, IN, USA),
anti-Bax (rabbit polyclonal, sc-526), anti-Bcl-2 (mouse mono-
clonal, sc-509), and anti-b-actin (mouse monoclonal, sc-8432), all
from Santa Cruz Biotechnology, Santa Cruz, CA, USA. Secondary
anti-mouse (NIF 825) and anti-rabbit (NIF 824) conjugated
to horseradish peroxidase were from Amersham Pharmacia
(Piscataway, NJ, USA). Primary and secondary antibodies were
incubated for 1h followed by three washes in PBST. Immuno-
complexes were detected with the ECL Plus Western blot detection
kit (Amersham Pharmacia, Piscataway, NJ, USA).
Rhodamine 123 fluorescence assay
Morphology of mitochondria was analysed using the cationic
fluorophore rhodamine 123 which specifically localises mitochon-
dria in living cells. Due to the negative electric potential across the
mitochondrial membrane rhodamine 123 transfers electrophor-
etically into the mitochondria (Johnson et al, 1980). Before
experiments, cells were grown on glass coverslips in 35-mm
culture dishes for 2 days. After treatment, 4ml of rhodamine 123
stock solution (1.5mM in medium containing 10% DMSO) were
added to the dishes to achieve a final concentration of 1.5mM and
incubated for 20min. Then, coverslips were washed twice with
medium to remove extracellular rhodamine. Cells were analysed
either by phase contrast microscopy to monitor cell morphology
or by fluorescence microscopy to determine mitochondrial
morphology. For fluorescence microscopy, excitation and emission
wavelength were 480 or 525nm, respectively.
RESULTS
The effect of MR-4 and R-3 on normal and transformed
human fibroblasts
We first compared the effects of MR-4 and R-3 on the growth of
normal and transformed human fibroblasts using the MTT-
reduction assay (Figure 1A). We also employed the crystal violet
staining assay to monitor cell proliferation (Figure 1B). We found
that both methods yielded qualitatively similar results. Human
fibroblast WI38 and the virally transformed WI38 (termed
WI38VA) were used as a model for paired normal and cancer
cells in this study. Both cell lines exhibit comparable growth rate
with the doubling time about 24h. For WI38 cells, both MR-4 and
R-3 showed little or no inhibitory effect up to 50–100mM as
determined by the MTT- or crystal violet assay. For WI38VA cells,
MR-4 completely inhibited the growth at 1–2mM, whereas R-3 was
much less potent, being effective only at concentrations greater
than 50mM. Thus, MR-4 was about 100-fold more potent than R-3
in inhibiting the growth of transformed WI38VA cells. In addition
to the MTT- and crystal violet assay, we also quantified the effect
of MR-4 on growth rates of WI38 and WI38VA cells by viable cell
counting (Figure 1C). When exposed to 0.5 or 1mM, the differential
growth inhibitory effect was evident 3 days after treatment. In
summary, all three proliferation assays demonstrate that MR-4
exhibited a clear differential growth inhibitory effect toward
transformed human cells. Moreover, MR-4 was about 50- to 100-
fold more potent than R-3 in inhibiting the growth of transformed
cells.
Effects of MR-4 on other normal and cancerous human
cells
The differential growth inhibitory effect of MR-4 on transformed
WI38VA cells prompted us to examine whether this finding also
holds for other cancer cell types. Figure 2 shows the phase contrast
micrographs of three normal, two virally transformed (WI38VA,
IMR-90SV), and one cancer cell line (HeLa) in the presence of 1 or
10mM of MR-4. At both concentrations MR-4 inhibited the growth
of transformed and cancer cells. MR-4 also inhibited the growth of
LNCaP prostate cancer cells, HT-29 colon cancer cells, and HepG2
hepatoma cells with the IC50 values in the range of 1–5mM (data
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suppress the growth of normal cells such as WI38, IMR90, and
BJ-T. Although MR-4 did not affect the growth and viability of the
normal cells, it did cause slight changes in cell morphology at high
concentrations (410mM). These results suggest that the differ-
ential growth inhibitory effect of MR-4 appeared to be general for
transformed and cancerous cells.
Effect of MR-4 on apoptosis in normal and transformed
human fibroblasts
Abundant literature evidence suggests that the antiproliferative
effect of resveratrol is due to its ability to induce apoptosis
(Gusman et al, 2001). It is therefore likely that the differential
growth inhibitory effect of MR-4 may be due to selective induction
of apoptosis in transformed cells, but not in normal cells. To
examine this possibility, we first determined whether MR-4 could
elicit DNA laddering, a signature event of apoptotic process
(Compton, 1992; Green and Reed, 1998; vanGurp et al, 2003).
Figure 3A shows an extensive DNA fragmentation in transformed
WI38VA cells 48h after MR-4 treatment. In contrast, DNA
laddering was not observed in normal WI38 cells throughout the
entire time course. Caspases are a family of aspartyl-specific
cysteine proteases that play a key role in transmitting and
executing a whole array of apoptotic signals (Budihardjo et al,
1999). We therefore also examined whether MR-4 had differential
effects on global caspase activation. Figure 3B shows that the
activation of caspases occurred only in WI38VA cells following
MR-4 treatment, but not in WI38 cells. These results indicate that
MR-4 selectively induced apoptotic signalling pathways in
transformed cells but not in normal cells.
Effect of MR-4 on the expression of apoptosis-related
genes in normal and transformed human fibroblasts
Mitochondria-mediated apoptotic pathways involve modulation of
the expression of genes such as p53, the key upstream player in
apoptosis, and Bcl-2 family genes (Green and Reed, 1998; Sheikh
and Fornace, 2000). The Bax/Bcl-2 ratio has been considered to be
a rheostat of the apoptosis because it is related to the control of the
permeability of mitochondrial membranes via oligomerisation
mechanism (Korsmeyer et al, 1993; Korsmeyer, 1999). Induction of
p53, both at mRNA and protein level, in cells treated with
resveratrol is thought to be the major cause for apoptosis (Huang
et al, 1999). To examine whether MR-4 affects p53 and Bcl-2 family
genes, we performed RT–PCR and Western blot analysis in
normal and transformed fibroblasts.
Figure 4A shows that at the mRNA level, the ratio of Bax and
Bcl-2 gene expression increased in WI38VA cells and the value
reached to four-fold 6h after the MR-4 treatment while the Bax/
Bcl-2 ratio in WI38 cells decreased after MR-4 treatment. When
analysed at protein level, we observed a prominent increase of p53
by more than 10-fold in WI38VA cells within 4h (Figure 4B).
Moreover, we noticed that although the Bcl-2 level in WI38VA cells
treated with MR-4 did not show significant change, an additional
protein band appeared, most likely due to phosphorylation of Bcl-2
(Haldar et al, 1995). Consistent with the increase in the Bax/Bcl-2
mRNA ratio, Bax protein level also increased in WI38VA cells 8–
12h after MR-4 treatment (Figure 4B). In contrast, the p53, Bcl-2
and Bax level in WI38 cells were barely or much less detectable
even after 12h of MR-4 treatment (Figure 4B). These results show
that MR-4 selectively induced an increase in p53 and Bax/Bcl-2
ratio, consistent with the notion that MR-4 treatment activated
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Figure 1 Growth inhibition induced by MR-4 and R-3 in normal and transformed fibroblasts. Normal (WI38; left panel) or transformed fibroblasts
(WI38VA; right panel) were treated by different concentrations of MR-4. Then, cell growth was either analysed by (A) the MTT-assay and (B) the crystal
violet assay after 5 days or by (C) cell counting after different time points as described in Material and Methods. For cell counting, cells were treated by
0.5mM (closed squares), 1mM (closed triangles), or were left untreated as controls (open circles) and counted at indicated times. Results obtained by the
MTT- or crystal violet assay were documented by a scanner (A, B) or expressed as cell numbers for the cell counting method (C). Representative data of
three independent experiments are shown.
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smitochondria-mediated apoptotic pathways only in transformed
cells.
Mitochondrial morphology and distribution in normal and
transformed human fibroblasts
The upregulation of the Bax/Bcl-2 ratio and p53 prompted us to
analyse possible effect of MR-4 on the mitochondrial morphology
and distribution. Cationic fluorophore rhodamine 123 stains intact
mitochondria rather specifically (Johnson et al, 1980). We
therefore employed rhodamine 123 to monitor possible changes
in mitochondrial localisation and clustering in normal and
transformed fibroblasts following the MR-4 treatment. We found
a drastic change in mitochondrial morphology only in WI38VA
cells treated by MR-4. As shown in Figure 5A, MR-4 induced a
dose-dependent perinuclear clustering of mitochondria in trans-
formed WI38VA cells, but not in their normal counterpart, WI38
cells. Figure 5B shows the effect of MR-4 on mitochondrial
distribution in WI38VA cells at higher magnification. Mitochon-
dria in control WI38VA cells were distributed throughout the cell
0
BJ-T WI38 HeLa IMR-90 WI38VA IMR-90SV MR-4 (M)
10
1
Figure 2 Morphology of various normal and cancer cells after treatment by MR-4. Different normal cell strains including WI38 (normal lung fibroblasts),
BJ-T (normal foreskin fibroblasts transfected with telomerase), and IMR-90 (normal fibroblasts) as well as transformed or cancer cell lines including WI38VA
(SV40 virally transformed lung fibroblasts), IMR-90SV (SV40 virally transformed fibroblast), and HeLa (cervix cancer) were treated with 1 or 10mM of MR-4
for 5 days. Morphological analysis was performed by phase contrast light microscopy.
Time (h) 0 6 12 24 48 72
WI38
0 6 12 24 48 72
WI38VA
Control
MR-4
A
B
Figure 3 Analysis of apoptotic cell death by (A) DNA fragmentation and (B) caspase activation assay in normal and transformed fibroblasts. Confluent
WI38 or WI38VA cultures were treated with MR-4 (50mM) and processed for apoptosis assay. (A) DNA laddering. DNA was isolated from cells at
indicated time points and analysed by agarose electrophoresis and ethidium bromide staining. (B) Caspase activation-assay. After 48h of MR-4 treatment,
the effect on caspase activation was analysed by the CaspACEt in situ marker FITC-VAD-FMK, which specifically binds to the activated caspases. After an
incubation of 20min with the fluorophore, cells were examined by fluorescent microscopy. For each treatment, representative phase contrast (left) and
fluorescence (right) micrographs were taken. Upper and lower panels represent controls or MR-4 treated cells, respectively.
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sbody, but became aggregated and clustered around the nucleus
(perinuclear clustering) after only 3h after MR-4 treatment
(Figure 5B, bottom vs top). In contrast, the web-like cellular
distribution of mitochondria in normal cells was not significantly
affected by MR-4 up to 100mM. In a time course study using only
5mM MR-4, we observed prominent aggregation of mitochondria
in WI38VA cells 6h after the treatment (data not shown). When
the effect of R-3 was analysed (Figure 5C), we found that R-3 did
cause apoptosis and clustering of mitochondria in WI38VA cells,
but only at much higher concentrations, up to 500mM. Figure 5D
shows the mitochondrial clustering induced by R-3 at 500mM in
WI38VA cells. The clustering induced by R-3 was not as prominent
and clear as that observed with MR-4 (Figure 5D vs Figure 5B). The
effect of MR-4 on mitochondrial clustering was quite dramatic and
it was evident even without fluorescent staining (Figure 5B). The
observation that MR-4 significantly altered the morphology and
distribution of mitochondria in transformed fibroblasts suggests
that MR-4 may specifically evoke death signals originating from
mitochondria in transformed cells. The fact that R-3 caused
apoptosis and mitochondrial clustering only at much higher
concentration suggests that MR-4 and R-3 may share a common
target site, but the action of MR-4 is more specific and potent.
DISCUSSION
It has been shown that resveratrol attenuates carcinogenesis or
tumour progression both in vitro and in vivo, and is likely the key
ingredient for the health beneficial effect of grape wine (Jeandet
et al, 1991; Jang et al, 1997; Elattar and Virji, 1999; Hsieh and Wu,
1999; Lu and Serrero, 1999; Surh et al, 1999; Tsan et al, 2000;
Gusman et al, 2001; Ding and Adrian, 2002; Narayanan et al, 2003;
Zhou et al, 2003). Although the antiproliferative effect of
resveratrol seems to be due to the induction of apoptosis (Hsieh
and Wu, 1999; Surh et al, 1999; Tsan et al, 2000; Ding and Adrian,
2002; Zhou et al, 2003), current research on the use of resveratrol
as potential cancer chemoprevention agent has been largely limited
to the study with only cancer cells. In an attempt to determine
whether chemical modification of the stilbene backbone of
resveratrol may further enhance its biological activity and
differentiate cancer cells from their normal counterparts, we have
synthesised and tested a number of hydroxy- and methoxy-
stilbenes (Lu et al, 2001). Among them, MR-4 is by far not only the
most potent one but also is the one that exhibits the most striking
differential growth inhibitory effect against cancer cells (Figures 1
and 2). As previously noted (Chen et al, 1998; Lu et al, 2001;
Gosslau and Chen, 2004), when tested as a potential anticancer
agent it is desirable that the compound has minimal detrimental
effect on the growth or survival of normal cells. In this regard,
MR-4 may be superior to natural resveratrol as a candidate for
chemoprevention agent. Nevertheless, further work on toxicity is
needed to establish this possibility. Since MR-4 did not exhibit any
antioxidant activity as demonstrated by the thiobarbituric acid
assay (A Gosslau and KY Chen, unpublished result), the enhanced
anticancer activity of MR-4 does not appear to be related to
antioxidation, as known to be associated with various polyphenol
compounds. The fact that R-4 and MR-4, but not R-3 or MR-3 (the
trimethoxy derivative of R-3), exhibits differential growth in-
hibitory effect (Lu et al, 2001 and Figures 1 and 2) suggests that
structure-related mechanisms (an additional hydroxyl or methoxyl
group) may be crucial in revealing the target sites that differentiate
cancer cells from their normal counterparts. On the other hand, we
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Figure 4 Effect of MR-4 on the expression of apoptotic genes in normal and transformed fibroblasts. (A) RT–PCR analysis. MR-4 (50mM) was applied for
0, 2, 4, or 6h to WI38 or WI38VA. The induction of Bax and Bcl-2 was analysed by RT–PCR using 1mg of total RNA. Glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) was used as internal standard. Bax/Bcl-2 ratio was determined by densitometry and normalised to GAPDH. (B) Western blot
analysis. MR-4 (50mM) was applied for 0, 4, 8, or 12h. Cells were harvested at indicated times and equal amount of cellular protein (30mg) was analysed by
SDS–PAGE. Western blot analysis was performed using specific antibodies against Bax, Bcl-2, p53, and actin as described in Materials and Methods.
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scannot rule out the possibility that the differences between the
effects of R-3 and MR-4 reflect differences in the uptake of these
compounds.
The close correlation between the growth inhibition (Figures 1
and 2) and the effect of MR-4 on apoptosis in transformed cells, as
determined by morphological damage, DNA laddering and caspase
activation (Figure 3), suggest that the target sites of MR-4 could be
any components involved in apoptotic pathway or the upstream
events that lead to apoptosis. The tumour suppressor protein p53
is known to function as a gatekeeper controlling critical cell cycle
checkpoints (Levine, 1997) and also act as a key player in
mediating apoptosis through modulating the Bax to Bcl-2 ratio and
the regulation of mitochondrial ROS generation (Miyashita and
Reed, 1995; Johnson et al, 1996; Levine, 1997; Yin et al, 1997;
Sheikh and Fornace, 2000; Pietenpol and Stewart, 2002). The
findings that MR-4 led to the induction of p53, increases in Bax
and Bax/Bcl-2 ratio (Figure 4) and caused a rapid perinuclear
clustering of mitochondria (Figure 5) in transformed cells, but not
in normal cells, could explain the selective apoptotic effect of MR-4
in cancer cells. The appearance of Bcl-2 doublet in MR-4 treated
WI38VA cells (Figure 4B) also suggests that the phosphorylation of
Bcl-2 may contribute to the apoptotic process in transformed cells,
as it has been shown that Bcl-2 phosphorylation not only
inactivates itself but also facilitates permeabilisation of mitochon-
dria membrane (Haldar et al, 1995).
In accordance with the notion that MR-4 may trigger the
mitochondria-mediated apoptosis in transformed cells, we ob-
served prominent condensation and clustering of mitochondria
around the nucleus in cancer cells, but not in normal cells after
MR-4 treatment (Figure 5A and B). This dramatic morphological
change becomes obvious within 3h after treatment and represents
one of the earlier events induced by MR-4. Our observation that
R-3 also induced clustering of mitochondria, although at much
higher concentrations as compared to MR-4 (Figure 5C and D),
suggests that MR-4 and R-3 may share a common target site. Other
investigators have reported that mitochondria-mediated apoptosis
sometimes is accompanied with morphological changes and
redistribution of mitochondria in apoptotic cells (Desagher and
WI38VA 
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WI38VA 
(MR-4, 100M)
B A WI38 
WI38VA  
MR-4  25 50 100    (M)
WI38VA  C D
R-3  (M)
WI38VA 
(R-3, 500M)
0
100 250 500 0
Figure 5 Effect of MR-4 and R-3 on the mitochondrial morphology in normal and transformed fibroblasts. (A) Dose–response study of the effect of
MR-4 on mitochondrial localisation in WI38 and WI38VA cells. Cells were treated with different concentrations of MR-4 for 3h and then stained with
rhodamine 123 for 20min. Cells were then analysed either by phase contrast (top of each panel) or fluorescence microscopy (bottom of each panel) at a
final magnification of  1000. (B) Effect of MR-4 on WI38VA cells. Cells treated without (control) or with MR-4 (100mM) for 3h and analysed at a
magnification of  5000. (C) Dose–response study of the effect of R-3 on mitochondrial localisation in WI38VA cells. Cells were treated with R-3 at
indicated concentrations for 3h and then stained with rhodamine123 for 20min and then analysed by phase contrast (top panels) and fluorescent (bottom
panels) microscopic examination. (D) Effect of R-3 on WI38VA cells. Cells were treated with R-3 at 500mM for 3h and then examined under phase contrast
(upper) and fluorescent (bottom) microscopy at a magnification of  5000.
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sMartinou, 2000). The mechanism of clustering is unknown. The
possible causal relationship between mitochondria clustering and
apoptosis needs to be clarified. One possible scenario is that MR-4
causes mitochondrial clustering and depolarisation in cancer cells,
which results in the release of proapoptotic factors and triggers
apoptosis. We observed the formation of crystal-like structures
specifically around mitochondria of transformed fibroblasts
treated by MR-4 (Figure 5B). The identification of the nature of
these structures may help to resolve the apoptotic mechanisms
induced by MR-4 in cancer cells. In addition, other targets of MR-4
particularly can be further investigated by microarray technology.
Taken together, our data show that the resveratrol analogue
MR-4 exhibits potent and selective growth inhibitory effect to
cancer cells. The specific induction of perinuclear clustering of
mitochondria and the activation of the mitochondria-mediated
apoptotic pathway seem to be the major cause for the striking
differential inhibitory effect of MR-4. Identification of the target of
MR-4 in cancer cells will be the key for our understanding of the
action of MR-4. A major challenge in cancer therapy is to search or
synthesise drugs that kill tumour cells while preserve normal cells.
In this regard, polyhydroxystibene may serve as a useful chemical
platform for developing more potent and selective anticancer
reagents.
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